Müller M - Search Results

1

Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.

Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Østergaard L, Søgaard OS. Toft L, et al. Among authors: muller m. Hum Vaccin Immunother. 2014;10(5):1147-54. doi: 10.4161/hv.27925. Epub 2014 Feb 19. Hum Vaccin Immunother. 2014. PMID: 24553190 Free PMC article. Clinical Trial.

2

HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.

Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M. Sehr P, et al. Among authors: muller m. J Virol Methods. 2002 Oct;106(1):61-70. doi: 10.1016/s0166-0934(02)00134-9. J Virol Methods. 2002. PMID: 12367730

3

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Ohlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G, Gissmann L. Ohlschläger P, et al. Among authors: muller m. J Virol. 2003 Apr;77(8):4635-45. doi: 10.1128/jvi.77.8.4635-4645.2003. J Virol. 2003. PMID: 12663770 Free PMC article.

4

Development of prophylactic HPV vaccines.

Gissmann L, Müller M. Gissmann L, et al. Among authors: muller m. Coll Antropol. 2007 Apr;31 Suppl 2:113-5. Coll Antropol. 2007. PMID: 17598512 Review.

5

Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.

Rizk RZ, Christensen ND, Michael KM, Müller M, Sehr P, Waterboer T, Pawlita M. Rizk RZ, et al. Among authors: muller m. J Gen Virol. 2008 Jan;89(Pt 1):117-129. doi: 10.1099/vir.0.83145-0. J Gen Virol. 2008. PMID: 18089735

6

Immunogenicity of an HPV-16 L2 DNA vaccine.

Hitzeroth II, Passmore JA, Shephard E, Stewart D, Müller M, Williamson AL, Rybicki EP, Kast WM. Hitzeroth II, et al. Among authors: muller m. Vaccine. 2009 Oct 30;27(46):6432-4. doi: 10.1016/j.vaccine.2009.06.015. Epub 2009 Jun 24. Vaccine. 2009. PMID: 19559114 Free PMC article.

7

Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.

Nieto K, Kern A, Leuchs B, Gissmann L, Müller M, Kleinschmidt JA. Nieto K, et al. Among authors: muller m. Antivir Ther. 2009;14(8):1125-37. doi: 10.3851/IMP1469. Antivir Ther. 2009. PMID: 20032542

8

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.

Rubio I, Seitz H, Canali E, Sehr P, Bolchi A, Tommasino M, Ottonello S, Müller M. Rubio I, et al. Among authors: muller m. Virology. 2011 Jan 20;409(2):348-59. doi: 10.1016/j.virol.2010.10.017. Epub 2010 Nov 11. Virology. 2011. PMID: 21074234 Free article.

9

Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.

Nieto K, Stahl-Hennig C, Leuchs B, Müller M, Gissmann L, Kleinschmidt JA. Nieto K, et al. Among authors: muller m. Hum Gene Ther. 2012 Jul;23(7):733-41. doi: 10.1089/hum.2011.202. Epub 2012 Apr 18. Hum Gene Ther. 2012. PMID: 22401308 Free PMC article.

10

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.

Nieto K, Weghofer M, Sehr P, Ritter M, Sedlmeier S, Karanam B, Seitz H, Müller M, Kellner M, Hörer M, Michaelis U, Roden RB, Gissmann L, Kleinschmidt JA. Nieto K, et al. Among authors: muller m. PLoS One. 2012;7(6):e39741. doi: 10.1371/journal.pone.0039741. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,904 results

Search Page